Abstract
Guanine-rich DNA sequences can form planar four-stranded structures via Hoogsteen hydrogen bonds. These sequences in telomeric DNA and some oncogenes have been identified as targets for novel anticancer drugs. Consequently, there is great current interest in developing small molecules that can facilitate the formation of, and stabilize G-quadruplexes as potent antitumor chemotherapeutic agents. Metal complexes with planar geometries and π-delocalised ligands are emerging as a new class of quadruplex DNA ligand with unique features for optimal binding. This review will summarize the different types of metal-based compounds that target G-quadruplexes and provide useful information on the design of small ligands.
Keywords: G-quadruplexes, telomeric DNA, telomeres, targets, anticancer drug, metal complexes, ligand, stabilization
Mini-Reviews in Medicinal Chemistry
Title: Metallo-Organic G-Quadruplex Ligands in Anticancer Drug Design
Volume: 10 Issue: 8
Author(s): Y.-L. Jiang and Z.-P. Liu
Affiliation:
Keywords: G-quadruplexes, telomeric DNA, telomeres, targets, anticancer drug, metal complexes, ligand, stabilization
Abstract: Guanine-rich DNA sequences can form planar four-stranded structures via Hoogsteen hydrogen bonds. These sequences in telomeric DNA and some oncogenes have been identified as targets for novel anticancer drugs. Consequently, there is great current interest in developing small molecules that can facilitate the formation of, and stabilize G-quadruplexes as potent antitumor chemotherapeutic agents. Metal complexes with planar geometries and π-delocalised ligands are emerging as a new class of quadruplex DNA ligand with unique features for optimal binding. This review will summarize the different types of metal-based compounds that target G-quadruplexes and provide useful information on the design of small ligands.
Export Options
About this article
Cite this article as:
Jiang Y.-L. and Liu Z.-P., Metallo-Organic G-Quadruplex Ligands in Anticancer Drug Design, Mini-Reviews in Medicinal Chemistry 2010; 10 (8) . https://dx.doi.org/10.2174/138955710791572433
DOI https://dx.doi.org/10.2174/138955710791572433 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Absolute Quantification of Human Uridine-Diphosphate Glucuronosyl Transferase (UGT) Enzyme Isoforms 1A1 and 1A6 By Tandem LC-MS
Drug Metabolism Letters The Renin-Angiotensin System: New Insight into Old Therapies
Current Medicinal Chemistry Therapeutic Targets for the Management of Peripheral Nerve Injury- Induced Neuropathic Pain
CNS & Neurological Disorders - Drug Targets Targeted Protein Degradation: An Emerging Therapeutic Strategy in Cancer
Anti-Cancer Agents in Medicinal Chemistry An HPLC-MS/MS Method for the Quantitative Determination of Ticagrelor and its Active Metabolite AR-C124910XX in Human Plasma and its Application to a Clinical Study
Current Pharmaceutical Analysis Antiglucocorticoids, Neurogenesis and Depression
Mini-Reviews in Medicinal Chemistry IL-6 Signaling and its Blockade with a Humanized Anti-Interleukin-6 Receptor Antibody in Rheumatoid Arthritis: Advent of a New and Innovative Therapeutic Drug, Tocilizumab
Current Rheumatology Reviews Chemotherapy and Cardiotoxicity in Hematologic Malignancies
Current Cancer Drug Targets Flavonoids and Dementia: An Update
Current Medicinal Chemistry HIV-2 Infection and Chemokine Receptors Usage - Clues to Reduced Virulence of HIV-2
Current HIV Research Aberrant DNA Methylation and Prostate Cancer
Current Genomics HIV-1 Reverse Transcriptase: A Therapeutical Target in the Spotlight
Current Medicinal Chemistry Anti-Interleukin-6 Receptor Antibody Therapy in Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Therapeutic Potential of Metabotropic Glutamate Receptor Modulators
Current Neuropharmacology Genomic and Non-genomic Effects of Aldosterone
Current Signal Transduction Therapy Progress Toward Vector Design for Hematopoietic Stem Cell Gene Therapy
Current Gene Therapy Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment
Current Vascular Pharmacology Contextualizing Genetics for Regional Heart Failure Care
Current Cardiology Reviews Between Bench and Bed Side: PI3K Inhibitors
Current Molecular Pharmacology Chronic Kidney Disease and the Search for New Biomarkers for Early Diagnosis
Current Medicinal Chemistry